272 related articles for article (PubMed ID: 24660684)
1. QSAR guided semi-synthesis and in-vitro validation of anticancer activity in ursolic acid derivatives.
Kalani K; Yadav DK; Singh A; Khan F; Godbole MM; Srivastava SK
Curr Top Med Chem; 2014; 14(8):1005-13. PubMed ID: 24660684
[TBL] [Abstract][Full Text] [Related]
2. In-silico Studies and Wet-Lab Validation of Camptothecin Derivatives for Anti-Cancer Activity Against Liver (HepG2) and Lung (A549) Cancer Cell Lines.
Kalani K; Yadav DK; Alam S; Khan F; Kashyap MP; Srivastava SK; Pant AB
Curr Top Med Chem; 2021; 21(10):908-919. PubMed ID: 33902420
[TBL] [Abstract][Full Text] [Related]
3. 3D-QSAR and docking studies on ursolic acid derivatives for anticancer activity based on bladder cell line T24 targeting NF-kB pathway inhibition.
Yadav D; Nath Mishra B; Khan F
J Biomol Struct Dyn; 2019 Sep; 37(14):3822-3837. PubMed ID: 30261824
[TBL] [Abstract][Full Text] [Related]
4. QSAR and docking based semi-synthesis and in vitro evaluation of 18 β-glycyrrhetinic acid derivatives against human lung cancer cell line A-549.
Yadav DK; Kalani K; Khan F; Srivastava SK
Med Chem; 2013 Dec; 9(8):1073-84. PubMed ID: 23675978
[TBL] [Abstract][Full Text] [Related]
5. Pharmacophore, QSAR, and ADME based semisynthesis and in vitro evaluation of ursolic acid analogs for anticancer activity.
Kalani K; Yadav DK; Khan F; Srivastava SK; Suri N
J Mol Model; 2012 Jul; 18(7):3389-413. PubMed ID: 22271093
[TBL] [Abstract][Full Text] [Related]
6. 2D- and 3D-QSAR modelling, molecular docking and
Shukla A; Tyagi R; Meena S; Datta D; Srivastava SK; Khan F
J Biomol Struct Dyn; 2020 Jan; 38(1):168-185. PubMed ID: 30686140
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Biological Evaluation of Novel Ursolic acid Derivatives as Potential Anticancer Prodrugs.
Yang X; Li Y; Jiang W; Ou M; Chen Y; Xu Y; Wu Q; Zheng Q; Wu F; Wang L; Zou W; Zhang YJ; Shao J
Chem Biol Drug Des; 2015 Dec; 86(6):1397-404. PubMed ID: 26077799
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and in vitro evaluation of 18β-glycyrrhetinic acid derivatives for anticancer activity against human breast cancer cell line MCF-7.
Yadav DK; Kalani K; Singh AK; Khan F; Srivastava SK; Pant AB
Curr Med Chem; 2014; 21(9):1160-70. PubMed ID: 24180274
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and in vitro anticancer activity of novel quinoline and oxadiazole derivatives of ursolic acid.
Gu W; Jin XY; Li DD; Wang SF; Tao XB; Chen H
Bioorg Med Chem Lett; 2017 Sep; 27(17):4128-4132. PubMed ID: 28733083
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and in vitro evaluation of novel ursolic acid derivatives as potential anticancer agents.
Hua SX; Huang RZ; Ye MY; Pan YM; Yao GY; Zhang Y; Wang HS
Eur J Med Chem; 2015 May; 95():435-52. PubMed ID: 25841199
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, anticancer activity and QSAR study of 1,4-naphthoquinone derivatives.
Prachayasittikul V; Pingaew R; Worachartcheewan A; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Eur J Med Chem; 2014 Sep; 84():247-63. PubMed ID: 25019480
[TBL] [Abstract][Full Text] [Related]
12. Phenylpropiophenone derivatives as potential anticancer agents: synthesis, biological evaluation and quantitative structure-activity relationship study.
Ivković BM; Nikolic K; Ilić BB; Žižak ŽS; Novaković RB; Čudina OA; Vladimirov SM
Eur J Med Chem; 2013 May; 63():239-55. PubMed ID: 23501110
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antitumor activity evaluation of novel ursolic acid derivatives.
Meng YQ; Zhang LF; Liu DY; Liu LW; Zhang Y; Zhao MJ
J Asian Nat Prod Res; 2016; 18(3):280-8. PubMed ID: 26524942
[TBL] [Abstract][Full Text] [Related]
14. QSAR, docking, ADMET, and system pharmacology studies on tormentic acid derivatives for anticancer activity.
Alam S; Khan F
J Biomol Struct Dyn; 2018 Jul; 36(9):2373-2390. PubMed ID: 28705120
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and screening of ursolic acid-benzylidine derivatives as potential anti-cancer agents.
Dar BA; Lone AM; Shah WA; Qurishi MA
Eur J Med Chem; 2016 Mar; 111():26-32. PubMed ID: 26854375
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and cytotoxicity of novel ursolic acid derivatives containing an acyl piperazine moiety.
Liu MC; Yang SJ; Jin LH; Hu DY; Xue W; Song BA; Yang S
Eur J Med Chem; 2012 Dec; 58():128-35. PubMed ID: 23124210
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, evaluation and QSAR studies of 16-(4 & 3,4-substituted) benzylidene androstene derivatives as anticancer agents.
Dubey S; Kaur P; Jindal DP; Satyanarayan YD; Piplani P
Med Chem; 2008 May; 4(3):229-36. PubMed ID: 18473915
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of novel oleanolic acid and ursolic acid in C-28 position derivatives as potential anticancer agents.
Tian T; Liu X; Lee ES; Sun J; Feng Z; Zhao L; Zhao C
Arch Pharm Res; 2017 Apr; 40(4):458-468. PubMed ID: 28101738
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of ursolic acid-triazolyl derivatives as potential anti-cancer agents.
Rashid S; Dar BA; Majeed R; Hamid A; Bhat BA
Eur J Med Chem; 2013 Aug; 66():238-45. PubMed ID: 23811086
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative activity and QSAR studies of a series of new 4-aminomethylidene derivatives of some pyrazol-5-ones.
Marković V; Erić S; Stanojković T; Gligorijević N; Aranđelović S; Todorović N; Trifunović S; Manojlović N; Jelić R; Joksović MD
Bioorg Med Chem Lett; 2011 Aug; 21(15):4416-21. PubMed ID: 21733686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]